Success Amaechi

M.Sc., B.Sc.
Success Amaechi is a 2nd-year PhD in the Molecular Rheumatology research group.

Prior to joining the group, Success completed his M.Sc. in Immunology at Trinity College
Dublin in 2020. During his M.Sc., he performed his research under Prof. Derek Doherty’s
Tuberculosis Immunology group, where he assessed the role of Vd2 T cells in tuberculosis
pathogenicity and immunity.

From August 2021 to February 2022, Success worked as a research assistant in Prof. Cliona
O’Farrelly’s Comparative Immunology group, where he was an active member in the Viral
Resistance Project, an international partnership that sought to seek why certain individuals
were immune to COVICD-19 despite being in regular close contact with those that had
contracted the SARS-CoV-2 virus.

Success joined the Molecular Rheumatology group in March 2022, where he is investigating
the molecular pathotypes that distinguish rheumatoid and psoriatic arthritis. His research
primarily focuses on the inflammatory role that monocytes and monocyte-derived
macrophages contribute to both diseases.

To date, Success has presented at the following conferences:

American College of Rheumatology; San Diego, CA, United States; November 2023
‘Rheumatoid arthritis monocytes and monocyte-derived macrophages display heightened
inflammatory response, reduced endocytic capacity and distinct TET expression compared to
psoriatic arthritis.’ (Poster presentation)

Irish Society for Rheumatology Autumn Meeting; Killiney, Co. Dublin; October 2023
‘Rheumatoid arthritis monocytes and monocyte-derived macrophages display heightened
inflammatory response, reduced endocytic capacity and distinct TET expression compared to
psoriatic arthritis.’ (Poster presentation)

European Workshop for Rheumatology Research; Dublin; Ireland; March 2023
‘Differential activation and frequency of circulating monocytes in rheumatoid arthritis and
psoriatic arthritis.’ (Poster presentation)

Email: amaechsu@tcd.ie
LinkedIn: https://www.linkedin.com/in/success-amaechi/

Leave a comment